(Q39586790)

13 September 2017

title

Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys (English)

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

17 April 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

17 April 2022

author name string

Alvord EC Jr

1

1 reference

13 September 2017

E. C. Alvord

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A93874

17 April 2022

C. M. Shaw

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A93874

17 April 2022

S. Hruby

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A93874

17 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=93874

17 April 2022

publication date

1 December 1979

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410060603

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410060603

17 April 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

17 April 2022

1 reference

13 September 2017

volume

6

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

469-473

1 reference

Myelin basic protein administration in multiple sclerosis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410060603

Cellular hypersensitivity in attacks of multiple sclerosis: 1. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410060603

Effect of a synthetic polypeptide (COP 1) on patients with multiple sclerosis and with acute disseminated encephalomeylitis. Preliminary report

21 January 2018

1

31

433

Abramsky

1977

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

The onset and progression of the lesion in multiple sclerosis

17 April 2022

2

25

165

Adams

1975

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Acta Neurologica Scandinavica

17 April 2022

5

55

71

Alvord

1977

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

17 April 2022

7

122

333

Alvord

1965

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?

17 April 2022

Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys

12

volume

6

page(s)

461

0 references

17

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Immunoglobulin-containing cells in multiple-sclerosis plaques

19 November 2022

21

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Suppression of the Immune Response: Reversal of the Disease State with Antigen in Allergic Encephalomyelitis

19 November 2022

22

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Failure of basic protein therapy for multiple sclerosis

19 November 2022

24

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases

19 November 2022

28

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

The immunogenesis of the multiple sclerosis plaque

19 November 2022

30

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Pathology of the early lesion in multiple sclerosis

19 November 2022

32

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Multiple sclerosis: Sensitization to a myelin basic protein fragment (peptide T) encephalitogenic to primates

19 November 2022

37

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Allergy in the nervous system a review of the literature

19 November 2022

39

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer

19 November 2022

40

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis

19 November 2022

43

1 reference

https://api.crossref.org/works/10.1002/ANA.410060603

19 November 2022

Identifiers

1 reference

13 September 2017

1 reference